Antimicrobial susceptibility of Helicobacter pylori strains isolated in Colombia;Resistencia a metronidazol y claritromicina en aislamientos de Helicobacter pylori de pacientes dispépticos en Colombia

Revista Medica de Chile

Volumn 137, Issue 10, 2009, Pages 1309-1314

  Álvarez, Adalucy ^a   Moncayo, José Ignacio ^a   Santacruz, Jorge Javier ^a   Corredor, Luisa Fernanda ^a   Reinosa, Elizabeth ^a   Martínez, José William ^a   Beltrán, Leonardo ^a  

^a UNIVERSIDAD TECNOLÓGICA DE PEREIRA   (Colombia)

Author keywords

Antibacterial agents; Helicobacter pylori; Metronidazole

Indexed keywords

ANTIINFECTIVE AGENT; METRONIDAZOLE; RIBOSOME DNA;

ANTIBIOTIC RESISTANCE; ARTICLE; CLASSIFICATION; COLOMBIA; DRUG EFFECT; GENETICS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MUTATION;

ANTI-BACTERIAL AGENTS; COLOMBIA; DNA, RIBOSOMAL; DRUG RESISTANCE, BACTERIAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; METRONIDAZOLE; MICROBIAL SENSITIVITY TESTS; MUTATION;

EID: 71149091484     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Kusters J, Vliet A, Kuipers E. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev 2006; 19: 449-90.
2. Moncayo JI, Santacruz JJ, Álvarez AL, Franco B, López MA, Ángel A et al. Comparación de métodos diagnósticos en la infección por Helicobacter pylori en Quindío, Colombia. Colomb Méd 2006; 37: 203-12.
3. Megraud F. H pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut 2004; 53: 1374-84.
4. Datta S, Chattopadhyay S, Patra R, De R, Ramamurthy T, Hembram J et al. Most Helicobacter pylori strains of Kolkata in India are resistant to metronidazole but susceptible to other drugs commonly used for eradication and ulcer therapy. Aliment Pharmacol Ther 2005; 22: 51-7.
5. Toracchio S, Marzio L. Primary and secondary antibiotic resistance of Helicobacter pylori strains isolated in central Italy during the years 1998-2002. Dig Liver Dis 2003; 35: 541-5.
6. Chey W, Wong B. American College of Gastroenterology Guideline on the Management of Helicobacter pylori Infection. Am J Gastroenterology 2007; 102: 1808-25.
7. Abbles AZ, Simon I, Melton ER. Update on Helicobacter pylori Treatment. Am Fam Physician 2007; 75: 351-8.
8. Gómez M, Otero W, Gutiérrez O. Tratamiento de la infección por Helicobacter pylori en un grupo de médicos generales y especialistas en Colombia. Rev Col Gastroenterol 2007; 22: 7-16.
9. Megraud F, Lehours P. Helicobacter pylori detection and antimicrobial susceptibility testing. Clin Microbiol Rev 2007; 20: 280-322.
10. Glupczynski Y, Broutet N, Cantagrel A, Andersen LP, Alarcón T, López Brea M et al. Comparison of the Etest and agar dilution method for antimicrobial suceptibility testing of Helicobacter pylori. Eur J Clin Microbiol Infect Dis 2002; 21: 549-52.
11. Best L, Haldane DJ, Keelan M. Multilaboratory comparison of proficiencies in susceptibility testing of Helicobacter pylori and correlation between agar dilution and Etest methods. Antimicrob Agents Chemother 2003; 47: 3138-44.
12. Raymond JC, Burucoa O, Pietrini M, Bergeret A, Decoster A, Wann C et al. Clarithromycin resistance in Helico-bacter pylori strains isolated from French children: prevalence of the different mutations and coexistence of clones harboring two different mutations in the same biopsy. Helicobacter 2007; 12: 157-63.
13. Menard A, Santos A, Megraud F, Oleastro M. PCR-restriction fragment length polymorphism can also detect point mutation A2142C in the 23S rRNA gene, associated with Helicobacter pylori resistance to clarithromycin. Antimicrob Agents Chemother 2002; 46: 1156-8.
14. Debets-Ossenkopp YJ, Reyes G, Mulder J, Stegge BM, Peters JTAM, Savelkoul PHM et al. Characteristics of clinical Helicobacter pylori strains from Ecuador. J Antimicrob Chemother 2003; 51: 141-5.
15. Torres J, Camorlinga-Ponce M, Pérez-Pérez G, Madrazo de La Garza A, Dehesa M, González-Valencia G et al. Increasing multidrug resistance in Helicobacter pylori strains isolated from children and adults in México. J Clin Microbiol 2001; 39: 2677-80.
16. McMahon BJ, Hennessy TW, Bensler JM, Bruden DL, Parkinson AJ, Morris JM et al. The relationship among previous antimicrobial use, antimicrobial resistance, and treatment outcomes for Helicobacter pylori infections. Ann Intern Med 2003; 139: 463-9.
17. Albert J, Al-Mekhaizeem K, Neil L, Dhar R, Dhar PM, Al-Ali M et al. High prevalence and level of resistance to metronidazole, but lack of resistance to other antimicrobials in Helicobacter pylori, isolated from a multiracial population in Kuwait. Aliment Pharmacol Ther 2006; 24: 1359-66.
18. Farina N, Kasamatsu E, Samudio M, Morán M, Sanabria R, Laspina F. Susceptibilidad a antibióticos de cepas paraguayas de Helicobacter pylori aisladas de pacientes con enfermedad gastroduodenal. Rev Méd Chile 2007; 135: 1009-14.
19. González C, García A, Daroch F, Kawaguchi F, Solar H, Rivera N et al. Susceptibilidad in vitro de cepas de Helicobacter pylori: aislamiento de cepas resistentes a claritromicina. Rev Méd Chile 2001; 129: 643-6.
20. Mendoca S, Ecclissato C, Sartori MS, Godoy AP, Guerzoni RA, Degger M et al. Prevalence of Helicobac-ter pylori resistance to metronidazole, clarithromycin, amoxicillin, tetracycline, and furazolidone in Brazil. Helicobacter 2000; 5: 79-83.
21. Vallejos C, Garrido L, Cáceres D, Madrid AM, Defilippi C, Defilippi C et al. Prevalencia de la resistencia a metronidazol, claritromicina y tetraciclina en Helico-bacter pylori aislado de pacientes de la Región Metropolitana. Rev Méd Chile 2007; 135: 287-93.
22. Mohammadi M, Doroud D, Massarrat S. Clarithromycin resistance in Iranian H pylori strains before introduction of clarithromycin. Helicobacter 2003; 8: 79-80.
23. Taneike I, Goshi SM, Tamura Y. Emergence of clarithromycin-resistant Helicobacter pylori (CRHP) with a high prevalence in children compared with their parents. Helicobacter 2002; 7: 297-305.
24. Dailidiene D, Bertoli MT, Miciuleviciene J, Mukhopadhyay AK, Dailide G, Pascasio MA et al. Emergence of tetracycline resistance in Helicobacter pylori: multiple mutational changes in 16S ribosomal DNA and other genetic loci. Antimicrob Agents Chemother 2002; 46: 3940-6.
25. Dore MP, Graham DY, Sepúlveda AR. Different penicillin-binding protein profiles in amoxicillin-resistant Helicobacter pylori. Helicobacter 1999; 4: 154-61.
26. Wu H, Shi X, Wang HT, Liu JX. Resistance of Helicobacter pylori to metronidazole, tetracycline and amoxycillin. J Antimicrob Chemother 2000; 46: 121-3.
27. Rimbara E, Noguchi N, Yamaguchi T, Narui K, Kawai T, Sasatsu M. Development of a highly sensitive method for detection of clarithromycin-resistant Helicobacter pylori from feces. Curr Microbiol 2005; 51: 1-5.
28. Van Doorn LJ, Glupczynski Y, Kusters JG, Mégraud F, Midolo P, Maggi-Solca N et al. Accurate prediction of macrolide resistance in Helicobacter pylori by a PCR line probe assay for detection of mutations in the 23S rRNA gene: multicenter validation study. Antimicrob Agents Chemother 2001; 45: 1500-4.
29. Hulten K, Gibreel A, Sköld O, Engstrand L. Macrolide resistance in Helicobacter pylori: mechanism and stability in strains from clarithromycin-treated pa-tients. Antimicrob Agents Chemother 1997; 41: 2550-3.
30. Versalovic J, Osato MS, Spakovsky K, Dore MP, Reddy R, Stone GG et al. Point mutations in the rRNA of Helicobacter pylori associated with different levels of clarithromycin resistance. J Antimicrob Chemother 1997; 40: 283-6.
31. Alarcón T, Vega AE, Domingo D, Martínez MJ, López-Brea M. Clarithromycin resistance among Helicobacter pylori strains isolated from children: prevalence and study of mechanism of resistance by PCR-restriction fragment length polymorphism analysis. J Clin Microbiol 2003; 41: 486-99.
32. Domingo D, Alarcón T, Sanz JC, Sánchez I, López-Brea M. High frequency of mutations at position 2144 of the 23S rRNA gene in clarithromycin-resistant Helicobacter pylori strains isolated in Spain. J Antimicrob Chemother 1998; 41: 573-4.
33. Burucoa C, Landron C, Garnier M, Fauchere JL, Khan R, Rahman M. T2182C mutation is not associated with clarithromycin resistance in Helicobacter pylori. Anti-microb Agents Chemother 2005; 49: 868-70.